Simulmedia Partners with Healthcare Panels Firm M3 MI

New York ad tech company Simulmedia has partnered with self-reported healthcare data firm M3 MI, whose panel data will now allow pharma marketers to target patient audiences across streaming TV.

Simulmedia's Performance TV is a suite of products powered by the patented, AI-driven TV+ analytics and activation platform and delivering targeted video ad campaigns across all streaming and linear TV channels for more than 100 top brands. Simulmedia claims to be 'the only company to guarantee campaign performance, whether the goal is reach, custom targeting, or ROI'.

M3 MI - formerly known as Kantar Media Healthcare Research - provides syndicated audience research and advertising intelligence for the healthcare industry, plus opt-in consumer health audiences for activation. M3 MI is part of global research and data company M3, Inc.

Users of TV+ can now tap data from M3 MI's MARS Consumer Health Study for consent-based data to target relevant patient populations on CTV while respecting privacy and complying with legislation. They also receive real-time delivery performance metrics.

The approach uses propensity models from an off-line, people-based national consumer database to offer 'comprehensive audience coverage' while removing survey seed data and avoiding re-identification risks. Simulmedia SVP Business Development Pravin Chandiramani (pictured) comments: 'Pharma marketers face growing challenges in reaching their target audiences with precision while ensuring compliance with increasingly stringent privacy regulations. By partnering with M3 MI, we've integrated their first-party, consent-based data into our TV+ Advertising Platform, enabling pharma brands to target patient and caregiver audiences across streaming TV with unparalleled accuracy and security'.

The firms are online at www.simulmedia.com and www.m3globalresearch.com .